← Back to headlines
AstraZeneca Receives Approval for Camizestrant in Breast Cancer Treatment
The FDA has granted approval for AstraZeneca's camizestrant, marking a significant advancement in hormone receptor-positive breast cancer therapy.
4 Sept, 20:34 — 4 Sept, 20:34
Sources
Showing 1 of 1 sources
